Wells Fargo
HURA

Wells Fargo’s TuHURA Biosciences HURA Stock Holding History

Wells Fargo’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.38K Sell
1,873
-15,571
-89% -$36.3K ﹤0.01% 6248
2026
Q1 		$31.2K Sell
17,444
-20,764
-54% -$25.4K ﹤0.01% 5614
2025
Q4 		$28.9K Buy
38,208
+19,931
+109% +$38.1K ﹤0.01% 5693
2025
Q3 		$45.3K Buy
18,277
+3,202
+21% +$8.43K ﹤0.01% 5580
2025
Q2 		$33.6K Buy
15,075
+13,275
+738% +$44.9K ﹤0.01% 5645
2025
Q1 		$5.81K Hold
1,800
– – ﹤0.01% 6001
2024
Q4 		$7.36K Buy
1,800
+1,754
+3,813% +$9.32K ﹤0.01% 5994
2024
Q3 		$315 Buy
+46
New +$342 ﹤0.01% 6204
2024
Q2 		– Sell
-1
Closed -$3 – 7568
2024
Q1 		$3 Buy
+1
New +$4 ﹤0.01% 7440
2023
Q4 		– Hold
0
– – – 7549
2023
Q3 		– Hold
0
– – – 6930
2023
Q2 		– Hold
0
– – – 7067
2023
Q1 		– Hold
0
– – – 7182
2022
Q4 		– Hold
0
– – – 6865
2022
Q3 		– Hold
0
– – – 7531
2022
Q2 		– Hold
0
– – – 7654
2022
Q1 		– Hold
0
– – – 7985
2021
Q4 		– Hold
0
– – – 7936
2021
Q3 		– Hold
0
– – – 7638
2021
Q2 		– Hold
0
– – – 7573
2021
Q1 		– Hold
0
– – – 7499
2020
Q4 		– Hold
0
– – – 7133
2020
Q3 		– Hold
0
– – – 7028

Other funds holding HURA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Wells Fargo's HURA Position: Q2 2026 in Review

Wells Fargo reduced its TuHURA Biosciences (HURA) stake by 89% in Q2 2026, selling an estimated $36.3K and leaving 1,873 shares worth $4.38K. The position accounts for ﹤0.01% of the portfolio, ranked #6248.

Wells Fargo first reported a position in HURA in Q1 2024 and has held it in 9 quarters since. The position peaked at $45.3K in Q3 2025. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

  • Wells Fargo held 1,873 shares of TuHURA Biosciences worth $4.38K as of Q2 2026.
  • Wells Fargo sold 15,571 TuHURA Biosciences shares in Q2 2026, an estimated $36.3K.
  • TuHURA Biosciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6248 holding.
  • Wells Fargo first reported a position in TuHURA Biosciences in Q1 2024 and has held it in 9 quarters since.
  • Wells Fargo's TuHURA Biosciences position peaked at $45.3K in Q3 2025.
  • 90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.